Literature DB >> 21576641

Stat5: from breast development to cancer prognosis, prediction, and progression.

David Tweardy, Jenny C Chang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576641     DOI: 10.1200/JCO.2010.34.2014

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

Review 1.  Is there any role for new prognostic markers in breast cancer?

Authors:  Agustí Barnadas
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

2.  STAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes.

Authors:  Ling Zhao; Qingyuan Zhang; Xin Luan; Xu Huang; Shu Zhao; Hong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 3.  Bioprinting and Organ-on-Chip Applications Towards Personalized Medicine for Bone Diseases.

Authors:  Chiara Arrigoni; Mara Gilardi; Simone Bersini; Christian Candrian; Matteo Moretti
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

4.  STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomes.

Authors:  Haishan Zhao; Zhe Wang; Huizhe Wu; Qinghuan Xiao; Weifan Yao; Enhua Wang; Yong Liu; Minjie Wei
Journal:  Med Oncol       Date:  2014-12-07       Impact factor: 3.064

5.  Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells.

Authors:  Daniel R Premkumar; Esther P Jane; Ian F Pollack
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

6.  Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways.

Authors:  Eun Joung Lim; Dae Young Hong; Jin Hee Park; Youn Hee Joung; Pramod Darvin; Sang Yoon Kim; Yoon Mi Na; Tae Sook Hwang; Sang-Kyu Ye; Eon-Soo Moon; Byung Wook Cho; Kyung Do Park; Hak Kyo Lee; Taekyu Park; Young Mok Yang
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

7.  Exome analysis reveals differentially mutated gene signatures of stage, grade and subtype in breast cancers.

Authors:  You Li; Xiaosheng Wang; Suleyman Vural; Nitish K Mishra; Kenneth H Cowan; Chittibabu Guda
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

8.  Reversal of aberrant cancer methylome and transcriptome upon direct reprogramming of lung cancer cells.

Authors:  Dashayini Mahalingam; Chiou Mee Kong; Jason Lai; Ling Lee Tay; Henry Yang; Xueying Wang
Journal:  Sci Rep       Date:  2012-08-21       Impact factor: 4.379

9.  Enhanced T cell lymphoma in NOD.Stat5b transgenic mice is caused by hyperactivation of Stat5b in CD8+ thymocytes.

Authors:  Bo Chen; Bing Yi; Rui Mao; Haitao Liu; Jinhua Wang; Ashok Sharma; Stephen Peiper; Warren J Leonard; Jin-Xiong She
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

10.  Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts.

Authors:  Jin Hee Park; Pramod Darvin; Eun Joung Lim; Youn Hee Joung; Dae Young Hong; Eui U Park; Seung Hwa Park; Soo Keun Choi; Eon-Soo Moon; Byung Wook Cho; Kyung Do Park; Hak Kyo Lee; Myong-Jo Kim; Dong-Sik Park; Ill-Min Chung; Young Mok Yang
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.